1.The experimental progress on arsenic trioxide for non-APL and solid tumor
Maiyu ZHOU ; Zhuo ZHANG ; Jin ZHOU
Practical Oncology Journal 2015;(2):144-148
Arsenic trioxide(As2O3)effectively triggers apoptosis in acute promyelocytic leukemia (APL) cells and induces complete remission and cure in most APL patients ,if they can refrain from early mortality .In the last few years,it has been under investigation as a potential treatment for non -APL leukemia and a variety of sol-id tumors.In the meantime,it has been found that As2O3 also inhibits proliferation of non -APL leukemia cell and several solid tumor cell such as liver ,esophageal ,and gastric cancer cell in vitro or in vivo in the more and more studies .The molecular mechanisms that As 2 O3 induces cellular apoptosis in non APL leukemia cell and solid tumor cells have been discussed ,which also includes building new targeting preparation in order to obtain much more satisfying therapeutic effect and relieve its cellular toxic and side effect and so on.Here, we give a summary which is connected with the research progress above .
2.Laparoscopic cholecystectomy and laparoscopic common bile duct exploration in treatment of cholecvstolithiasis and choledocholithiasis
Bujian PAN ; Mengtao ZHOU ; Maiyu XU ; Feng CHEN ; Hongliang SONG
Chinese Journal of Hepatobiliary Surgery 2011;17(10):816-819
Objective To study the use of laparoscopic cholecystectomy (LC) and laparoscopic common bile duct exploration (LCBDE) in patients with cholecystocholedocholithiasis.Methods From July 2006 to June 2010,127 patients with cholecystocholedocholithiasis were treated either by LC+LCBDE (n=78) or LC+endoscopic sphincterotomy (EST,n=49).The treatment success rate,complications,retained bile duct stones rate,recovery of gastrointestinal function and hospital-stay were retrospectively analyzed.Results The LCBDE+ LC group:The operative success rate was 94.87 %.The incidence of postoperative complications was 5.41 %.The EST+ LC group:Complete removal of bile duct stones was achieved in 46 of 48 patients (95.92%).The incidence of postoperative complications was 12.77%.There was a significant difference in the incidences of postoperative complications between the EST+ LC group and the LCBDE+ LC group (P<0.05).The operative time and the cost for hospital stay between the two groups were significantly different (P<0.05).After a follow-up of 3.2 years (mean,range 1-5 years),there was no significant difference in long-term complications such as bile duct recurrent stones,duodenal papilla stenosis and cholangitis between the two groups (P<0.05).ConclusionsLCBDE was a safe,efficacious and feasible minimal invasiveness treatment for cholecystocholedocholithiasis.Primary closure of common bile duct in selected cases brought additional benefits to the minimal invasive technique.